RhumbLine Advisers’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.71M Buy
210,355
+27,446
+15% +$223K ﹤0.01% 1972
2025
Q1
$1.44M Buy
182,909
+23,645
+15% +$186K ﹤0.01% 1985
2024
Q4
$2.37M Sell
159,264
-2,571
-2% -$38.3K ﹤0.01% 1793
2024
Q3
$2.47M Sell
161,835
-4,000
-2% -$61.2K ﹤0.01% 1794
2024
Q2
$2.53M Sell
165,835
-6,838
-4% -$104K ﹤0.01% 1767
2024
Q1
$3.26M Buy
172,673
+1,335
+0.8% +$25.2K ﹤0.01% 1651
2023
Q4
$3.27M Buy
171,338
+1,489
+0.9% +$28.4K ﹤0.01% 1655
2023
Q3
$3.05M Buy
169,849
+4,063
+2% +$72.9K ﹤0.01% 1630
2023
Q2
$3.37M Sell
165,786
-295
-0.2% -$5.99K ﹤0.01% 1614
2023
Q1
$3.03M Buy
166,081
+3,044
+2% +$55.5K ﹤0.01% 1594
2022
Q4
$3.37M Buy
163,037
+4,682
+3% +$96.8K ﹤0.01% 1519
2022
Q3
$4.14M Buy
158,355
+12,608
+9% +$330K 0.01% 1345
2022
Q2
$3.69M Buy
145,747
+84,927
+140% +$2.15M 0.01% 1426
2022
Q1
$1.92M Sell
60,820
-4,597
-7% -$145K ﹤0.01% 1835
2021
Q4
$2.65M Sell
65,417
-86
-0.1% -$3.48K ﹤0.01% 1730
2021
Q3
$2.28M Sell
65,503
-25
-0% -$872 ﹤0.01% 1832
2021
Q2
$1.8M Buy
65,528
+17,755
+37% +$487K ﹤0.01% 2001
2021
Q1
$1.34M Sell
47,773
-3,588
-7% -$101K ﹤0.01% 2074
2020
Q4
$1.33M Buy
51,361
+5,126
+11% +$133K ﹤0.01% 2021
2020
Q3
$792K Sell
46,235
-2,687
-5% -$46K ﹤0.01% 2083
2020
Q2
$1.21M Sell
48,922
-5,436
-10% -$134K ﹤0.01% 1965
2020
Q1
$754K Buy
54,358
+5,145
+10% +$71.4K ﹤0.01% 2004
2019
Q4
$497K Buy
49,213
+354
+0.7% +$3.58K ﹤0.01% 2365
2019
Q3
$445K Buy
48,859
+4,660
+11% +$42.4K ﹤0.01% 2384
2019
Q2
$351K Buy
44,199
+4,664
+12% +$37K ﹤0.01% 2528
2019
Q1
$494K Sell
39,535
-307
-0.8% -$3.84K ﹤0.01% 2335
2018
Q4
$429K Buy
+39,842
New +$429K ﹤0.01% 2367